May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Atopy in Herpes Simplex Eye Disease.
Author Affiliations & Notes
  • T. Prabriputaloong
    Ophthalmology, UCSF–Francis I Proctor Foundation, San Francisco, CA
  • R. Mather
    Ophthalmology, UCSF–Francis I Proctor Foundation, San Francisco, CA
  • I.G. Wong
    Ophthalmology, UCSF–Francis I Proctor Foundation, San Francisco, CA
  • T.P. Margolis
    Ophthalmology, UCSF–Francis I Proctor Foundation, San Francisco, CA
  • D.C. Gritz
    Ophthalmology, Permanente Medical Group, Oakland, CA
  • Footnotes
    Commercial Relationships  T. Prabriputaloong, None; R. Mather, None; I.G. Wong, None; T.P. Margolis, None; D.C. Gritz, None.
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 1631. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      T. Prabriputaloong, R. Mather, I.G. Wong, T.P. Margolis, D.C. Gritz; Atopy in Herpes Simplex Eye Disease. . Invest. Ophthalmol. Vis. Sci. 2004;45(13):1631.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To determine the role of atopy in herpes simplex (HSV) eye disease. Method: A retrospective, population–based, cohort study was performed in 9 communities served by Kaiser Permanente health care in Northern California. All medical records of patients with diagnosis of HSV eye disease, from July 31, 1998 through June 30, 1999, were reviewed. Inclusion criteria was based on the documentation of HSV eye disease by clinical presentation, history and laboratory evaluation. Atopy was defined as an established diagnosis of atopic dermatitis (eczema), allergic rhinitis, asthma, and atopic conjunctivitis, in the medical record. All new onset cases were reviewed for recurrence rate through 2002. Result: In the 798,484 people studied, there were 71 new (incidence) cases and 54 previously diagnosed cases with recurrence of HSV eye disease. The overall incidence rate was 9.3/ 100,000 person–year. Of the incident patients, the mean follow–up time was 40 months (range 1 to 54). Thirteen of 71 (18.31%) incidence cases had recurrence of herpes. In incidence cases, there were 29 patients with atopy (40.85%). In the incident patients with recurrence, there were 4 patients with atopy (30.76%). There were 25 previously diagnosed cases, had atopy (46.30%). There was no significant difference of proportion of atopy or severe atopy between recurrence and non–recurrence new cases (2–sided Fishers exact, p=0.53 and 0.63 respectively). There was no difference of atopy ratio among new cases and active prevalence cases (2–sided Fishers exact, p=0.58). Conclusion: There was high prevalence of atopy in this cohort of patients with HSV eye disease. There was no significant difference of prevalence of atopy between new onset patients with recurrence versus and no recurrence nor between new cases and active prevalence cases. These data suggest that atopy may not influence the course of HSV eye disease. A case–control study is planned to further address the role of atopy in ocular herpes.

Keywords: herpes simplex virus • clinical (human) or epidemiologic studies: risk factor assessment • cornea: clinical science 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×